Marisa B Marques
Overview
Explore the profile of Marisa B Marques including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
155
Citations
2432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yarava A, Marshall C, Reichert D, Ye A, Khanal P, Robbins S, et al.
J Clin Transl Sci
. 2024 Dec;
8(1):e200.
PMID: 39655012
Introduction: In response to the COVID-19 pandemic, we rapidly implemented a plasma coordination center, within two months, to support transfusion for two outpatient randomized controlled trials. The center design was...
2.
Westbrook B, Taylor L, Wallace E, Marques M, May J
Thromb Res
. 2024 Sep;
243:109171.
PMID: 39340923
Heparin-induced thrombocytopenia (HIT) is a rare complication of heparin exposure with potential for significant morbidity and mortality. Early identification and treatment can prevent catastrophic thrombosis. Herein, we report the performance...
3.
May J, Hearld K, Ogunsile F, Kennamer G, Mitchell K, Taylor L, et al.
Res Pract Thromb Haemost
. 2024 Sep;
8(5):102537.
PMID: 39262647
Background: Heparin-induced thrombocytopenia (HIT) is a complication of heparin exposure associated with high risk for morbidity and mortality. Diagnosis and management are complex due to limitations of laboratory testing and...
4.
Jacobs J, Stanek C, Booth G, Symeonidis A, Shih A, Allen E, et al.
Am J Hematol
. 2024 Aug;
99(11):2063-2074.
PMID: 39136282
Prior studies have suggested that immune thrombotic thrombocytopenic purpura (iTTP) may display seasonal variation; however, methodologic limitations and sample sizes have diminished the ability to perform a rigorous assessment. This...
5.
Jacobs J, Guarente J, Karp J, Grossman B, Ziman A, McGonigle A, et al.
Lancet Reg Health Am
. 2024 May;
34:100761.
PMID: 38745885
No abstract available.
6.
Siniard R, Gangaraju R, May J, Marques M
Expert Rev Hematol
. 2023 Sep;
16(11):861-869.
PMID: 37767808
Introduction: Immune-mediated TTP (iTTP) is a rare condition without pathognomonic signs and symptoms. For this reason, the diagnosis of iTTP may be delayed or even missed, with potentially catastrophic consequences....
7.
Uhlich R, Hu P, Yazer M, Jansen J, Patrician P, Marques M, et al.
J Trauma Acute Care Surg
. 2023 Feb;
94(6):791-797.
PMID: 36808128
Background: Traumatic hemorrhage is the leading cause of preventable death. Early in the resuscitation, only RhD-positive red blood cells are likely to be available, which poses a small risk of...
8.
Oh J, Marques M, Xu X, Li J, Genschmer K, Phillips E, et al.
Transfusion
. 2023 Feb;
63(3):586-600.
PMID: 36752125
Background: The formation of extracellular vesicles (EVs) occurs during cold storage of RBCs. Transfusion of EVs may contribute to adverse responses in recipients receiving RBCs. However, EVs are poorly characterized...
9.
Staley E, Marques M, Siniard R, Lima J, Singh N
J Clin Apher
. 2023 Jan;
38(1):73-74.
PMID: 36642962
No abstract available.
10.
Tsitsikas D, Mihalca D, Hall J, May J, Gangaraju R, Marques M, et al.
J Clin Med
. 2022 Nov;
11(22).
PMID: 36431152
Thrombotic thrombocytopenia purpura is characterised by microangiopathic haemolytic anaemia and red cell fragmentation on the peripheral smear, neurological involvement and thrombocytopenia. Diagnosis in the context of sickle cell disease can...